No profile data available.
Scilex Holding Company (SCLX) is a healthcare company in the sedation pharmaceuticals industry, based in Palo Alto, United States, with about 34 full-time employees.
It reported revenue of $56.59 million for fiscal year 2024, up 21.1% from fiscal year 2023, and net income of -$72.81 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $10.56 million, down 26.8% from a year before. Its market capitalization was $20.54 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding reported $56.59 million in revenue for fiscal year 2024, up 21.1% from $46.74 million in fiscal year 2023. In Q3 2025 revenue was $10.56 million.
$20.54 million as of October 9, 2026.
Listed companies of a similar size in the same industry (sedation pharmaceuticals) include Pacira BioSciences, Inc. (PCRX), PRF Technologies Ltd. (PRFX).